Session Keynote Speakers

This page is currently under construction.

Please find below an overview of all the confirmed Session Keynote Speakers, in alfabetical order. New Session Keynote Speakers will be added regularly.
At a later date the abstract titles will be added to each of the Session Keynote Speakers.


AO Research Institute

Mauro graduated in Chemistry from Lausanne University. After his Ph.D., comparing the ECM of normal and carcinomas human breast tissues, he joined the Shriners Hospital in Montreal to work on growth plate. In 1995, he was appointed as an Assist. Prof. at the McGill University and head of the Biochemistry Unit of the Orthopaedic Laboratory. In 2000, he became the head of the Musculoskeletal Regeneration Program at the AO Research Institute, and since 2020 is the Vice-Director. He received the Marshall R. Urist Award in 2015 from the ORS, and he gave the Ian Macnab lecture (Canadian ORS) in 2019.


Queensland University of Technology (QUT)

Dr Mark C Allenby is a Lecturer and Advance Queensland research fellow at Queensland University of Technology coupling tissue systems models and bioimage analyses to engineer improved medical treatments using experimental and computational approaches. Allenby is an investigator in the Herston Biofabrication Institute at the Royal Brisbane & Women's Hospital in Australia. URL: https://staff.qut.edu.au/staff/mark.allenby

 


Wake Forest Institute for Regenerative Medicine

Dr. Allickson is Chief Manufacturing Development Center Officer at Wake Forest Institute for Regenerative Medicine. She heads the clinical translation team streamlining development to create a robust pipeline of products in early phase clinical trials including cellular therapy, genetically engineered cellular therapy, tissue engineered organs and tissues and devices. Prior to the Institute, she was Vice President of R&D and Laboratory Operations for Cryo-Cell International Inc with experience in Cellular Banking and Licensure of Technology. She has a Doctorate in Health Sciences- Clinical Immunology and has 30 years of experience in clinical translation of cellular therapies and regenerative medicine products.


University of Illinois at Chicago

Dr. Alsberg is the Richard and Loan Hill Professor of Bioengineering, Orthopaedics, Pharmacology, and Mechanical & Industrial Engineering at the University of Illinois at Chicago. His lab focuses on engineering new technologies to regenerate tissues and treat diseases through development of novel biomaterials and microenvironments. He’s co-authored >130 peer reviewed papers and book chapters, and his work has been recognized with AIMBE College of Fellows membership, the Ellison Medical Foundation New Scholar in Aging Award, the Crain’s Cleveland Business Forty Under 40 Award, and Visiting Professorships in Korea and Israel.
 


iBET - instituto Biologia Experimental e Tecnologica

Paula Alves is the CEO of iBET and Professor at NOVA University of Lisbon; She holds a Ph.D. in Biochemical Engineering and a BSc in Biochemistry; Working in Animal Cell Technology since 1990, Professor Alves’ research integrates cell metabolism understanding with biochemical engineering for the improvement of bioprocesses for production of biopharmaceuticals, also focusing on the development of new tools for pre-clinical research. She is currently the President of the European Society for Animal Cell Technology. Published over 250 papers, 35 book chapters, supervised 36 PhD students. In 2009 she received the Scientific Merit Award from NOVA University of Lisbon.

 


Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

Dr. Andrés holds a PhD in Biology from Barcelona University and had postdoctoral training in Harvard University (1991-1993) and Tufts University (1993-1995). He was appointed Assistant Professor by Tufts University (1995-2000) and joined in 1999 the Biomedicine Institute of Valencia-CSIC. In 2009, he joined the Spanish National Centre for Cardiovascular Research (CNIC), where he heads the Basic Research Department since 2015. He investigates cardiovascular disease and the role of lamin A/C in health and disease, including Hutchinson-Gilford progeria syndrome. Since 2015, he is member of the Progeria Research Foundation Medical Research Committee.


University at Buffalo


Praveen Arany received his dental degree and completed a joint PhD-Residency program at Harvard University as a Presidential Scholar. He pursued postdoctoral fellowships at IISc and NCI; served as an Assistant Clinical Investigator at NIDCR, Bethesda; and currently is Assistant Professor, Oral Biology and Biomedical Engineering, University at Buffalo. He has over 80 scientific publications incld book chapters; recipient of numerous awards; reviews and serves on editorial boards and grant agencies. He holds several leadership positions and is currently President, World Association for Photobiomodulation Therapy (WALT). His primary research focuses on the molecular mechanisms and clinical translation of Photobiomodulation therapy.


MERLN Institute, Maastricht University, Maastricht, The Netherlands

Elizabeth R. Balmayor is Assistant Professor at the MERLN Institute and associate researcher at the Mayo Clinic (Rochester/USA). She was trained as a Chemist and earned a Ph.D. in T.E.R.M. at the 3B’s research group in Portugal. 
She holds visiting professorships at the Peruvian University Cayetano-Heredia and at the UNESCO Biomaterials’ chair of the University of Havana.
Her research interests include complex biomaterial development for tissue interfaces, their interaction with stem and progenitor cells, and gene and transcript therapies for musculoskeletal regeneration. She is a pioneer in the application of chemically modified mRNA for bone healing.


Histograft, LLC


Dr. Bozo, MD,PhD, MBA is a maxillofacial surgeon, researcher in regenerative medicine field and biotechnology entrepreneur. Being involved in R&D projects in gene therapy and clinical practice in maxillofacial surgery, he co-founded “Histograft”, a Russian biotech company, with R.Deev, A.Isaev and HSCI investment in 2015. Four years later, the company brought to clinical practice the world’s first gene-activated bone substitute based on octacalcium phosphate and plasmid DNA encoding VEGFA gene. The product has been proven to be safe and effective for bone grafting and reconstructive surgery. Ongoing researches cover 3D-printing of gene-activated matrices and hydrogel platforms for non-viral gene delivery.


Nationwide Children's Hospital

Dr Breuer is the Director of the Regenerative Medicine Program at Nationwide Children's Hospital.  He is a Tenured Professor of Surgery at The Ohio State University and holds the Nationwide Endowed Chair for Surgical Research.  His research focuses on cardiovascular tissue engineering and its application in the treatment of congenital heart disease.  

 

 

 


Trinity College Dublin

Conor Buckley is Principal investigator (PI) in the Trinity Centre for Biomedical Engineering and the Advanced Materials and Bioengineering Research (AMBER) Centre at Trinity College Dublin, Ireland. His research focuses on novel biomaterials, biofabrication and cell-based strategies for tissue regeneration (https://www.buckleylab.eu/). He has published 70 international peer reviewed journal articles and over 180 conference publications. He recently received a European Research Council Award (ERC) Consolidator award to develop personalised medicine approaches to regenerating the intervertebral disc using gene activated biomaterials and in silico predictive modelling.
 


Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal

Joaquim Cabral is a Distinguished Professor of Instituto Superior Técnico, University of Lisbon, Portugal. He was the Founding Head of Department of Bioengineering and Founding Director of the Institute for Bioengineering and Biosciences. He is graduated in Chemical Engineering with a PhD and “Habilitation” degrees in Biochemical Engineering in 1983 and 1988, respectively. He was a post-doctoral fellow at Massachusetts Institute of Technology (1983-1984). He joined IST faculty as Assistant Professor in 1984 and became Associate Professor in 1987 and Full Professor of Chemical and Biological Engineering in 1992. He has authored more than 580 publications (WoS h index 55)


University of Edinburgh

 

 

 

Dr Callanan is a Senior lecturer and Principal Investigator at the University of Edinburgh’s Institute for Bioengineering. The Callanan group couple the interplay between in silico modelling and cellular experimentation with focuses on scaffold and drug testing platforms. The group’s emphasis is on developing biomaterials with particular interest in human decellularized extracellular matrix materials. Dr Callanan is an author of over 60 peer-reviewed journal publications and over 170 conference proceedings. His current research utilities tissue engineering with a focus to restore tissue function in chronic diseases such as osteoarthritis, cardiac, hepatic, and renal disease.
 


Department of Histolgy, School of Medicine University of Granada, Spain

Antonio Campos is Full Professor of Histology at the University of Granada. He has been president of the Spanish Society of Histology, Dean and director of the National Institute of Health Carlos III where he promoted new models of biomedical investigation programs.  Promoter of tissue engineering, his group has created artificial tissues that have already been transferred to the clinic.  He has published relevant books and papers in high impact factor journals related to tissue engineering and Medical Education. Member of the Spanish Royal Academy of Medicine he has received three honoris causa doctorates in Argentina, Dominican Republic and Portugal. 
 


University of Genova / Endolife Srl

Ranieri Cancedda MD, Professor Emeritus of Cell Biology and past Dean of the Biotechnology School at the Genova University, Italy, also served as Head of the Regenerative Medicine Laboratory at the San-Martino teaching hospital. He is the founder of the company Endolife Srl.  First President of the European Tissue Engineering Society, now the TERMIS European Chapter, is currently a Fellow of TERMIS. He is the author of more than 350 publications (h-index 86; citations >30,000), and inventor in 9 patents. Dr. Cancedda is Field Chief Editor of Frontiers in Bioengineering and Biotechnology and Specialty Chief Editor of the TERM section.

 


The University of Manchester

Sarah is currently Head of the Department of Materials at The University of Manchester which is home to nearly 2,000 students and staff. In addition she is also the UK Biomedical Materials champion for The Royce Institute of a £235million UK government investment for advanced materials. She is the Director of the EPSRC CDT in Advanced Biomedical Materials. She is also a committee member for the EPSRC Advanced Materials Strategic Working Group. She is also a panel member for MRC DPFS grant funding and Specialty Chief Editor for Regenerative Technologies, a specialty section of Frontiers in Medical Technology Journal.

 


National Institute for Materials Science

Prof. Dr. Guoping Chen is Group Leader of Research Center for Functional Materials, National Institute for Materials Science; Professor of Department of Materials Science and Engineering, University of Tsukuba. His research interests include tissue engineering, polymeric scaffolds, biomimetic biomaterials and surface modification. He has authored more than 280 publications. He is Associate Editor of Journal of Materials Chemistry B; Editorial Boards of Journal of Bioactive and Compatible Polymers, Journal of Tissue Engineering and Regenerative Medicine, Regenerative Biomaterials, Biomedical Materials and Bioactive Materials; Advisory Board of Biomaterials Science. He has been selected Fellow of RSC in 2015 and AIMBE in 2017.
 


Nanyang Technological University

Dr. Sing Yian CHEW is an Associate Professor at School of Chemical & Biomedical Engineering and Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore. Her most significant contribution is in the field of scaffold-mediated delivery of gene-silencing and biomimicking physical signals for neural tissue regeneration and remyelination. Dr. Chew serves as Editorial Board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology – Biomaterials, Journal of Biomedical Materials Research Part A, Drug Delivery and Translational Research, Experimental Neurology and Journal of Tissue Engineering. In addition, Dr. Chew is an Associate Editor in ACS Applied Materials & Interfaces."

 


UCL, London

Dr. Coffey received his D. Phil at Oxford University and was a member of the faculty at Oxford and later the University of Sheffield as Lecturer and Senior Lecturer. He was formerly Professor and Head of Ocular Biology and Therapeutics at the Institute of Ophthalmology at University College London, where he also served as Chair of Cellular Therapies and Visual Science. Dr. Coffey has received many honors and awards, including the prestigious Estelle Doheny Living Tribute Award in 2009, Retinitis Pigmentosa International's Vision Award in 2009, the CIRM Leadership Award in 2010, and the NYSCF Roberston Prize in 2011.


IRIBHM-ULB

Sabine Costagliola is Research Director at IRIBHM, Université Libre de Bruxelles (ULB), Belgium. She is laureate of several prizes for her contribution to thyroid and endocrine research and has a significant track record of high-profile publications in international Journals in the field. The main focus of her research is the molecular dissection of signaling mechanisms that control morphogenetic processes and gene networks involved in thyroid organogenesis with a working strategy combining several experimental models including Zebrafish and organoids.
 


Center of Experimental Orthopaedics, Saarland University Medical Center

Magali Cucchiarini, PhD, is a Group Leader and Vice-Director of the Center of Experimental Orthopaedics, Saarland University, Homburg/Saar, Germany. She graduated from the University of Nice-Sophia Antipolis, France (1992) and received her PhD from this University (Virology and Molecular Biology, summa cum laude, 1995). She was a senior post-doctoral fellow at the Harvard Institutes of Medicine, Boston, USA (HIV gene therapy) and at the Department of Internal Medicine, University Hospital Inselsspital, Bern, Switzerland (EU project, HCV vaccination). Her research interest is to generate cell-, gene-, and tissue engineered-based systems for musculoskeletal disorders.


University of Glasgow

Matthew became an independent researcher in 2003 securing a BBSRC Fellowship to explore mesenchymal stem cell response to nanotopography looking at self-renewal and differentiation. Appointed to a lectureship in 2008 and a Readership in 2010 he focussed more on control of mesenchymal stem cell self-renewal with nanotopography. In 2014 he became Professor of Cell Engineering at the University of Glasgow and diversified his research to include interests in low dose growth factor delivery which recently resulted in a first veterinary trial and development of a nanovibrational bioreactor that is being used to produce cells for a human trial.
 

 


University of Würzburg

Paul Dalton is a Professor in Biofabrication at the University of Würzburg. Graduating from Curtin University in Perth, Australia, he was part of a bioengineering team at the Lions Eye Institute that successfully took an artificial cornea from concept to the clinic. His career has an international perspective, with post-docs at the University of Toronto and RWTH-Aachen followed by research scientist positions at the University of Southampton and Shanghai Jiao Tong University. He invented and developed melt electrowriting as a distinct class within 3D printing with the Queensland University of Technology and has over 25 years’ experience across several disciplines.


The Ohio State University

In 1993 David Dean’s PhD thesis presented a template-based method for producing average 3D organ surface images. As a postdoctoral researcher at New York University he used average skull images as targets for surgical simulation and intra-operative guidance. Later at Case Western Reserve University he was the first person to use average surfaces to design and 3D print patient-specific cranial implants. His regenerative medicine research incorporates skeletal progenitor cells and 3D printing resorbable biomaterials. Since 2013 his research at The Ohio State University has included 3D printed NiTi for stiffness-matched skeletal fixation devices and Mg alloys for resorbable skeletal devices.


DWI - Leibniz Institute for Interactive Materials

Laura De Laporte designs Advanced Biomedical Systems that direct the interaction with cells. She studied Chemical Engineering in Ghent, where she got the tissue engineering microbe. During her PhD at Northwestern University, she engineered guiding implants for nerve regeneration, while her postdoc at EPFL in Jeffrey Hubbell’s group focused on smart hydrogels. Currently, she is a Leibniz Professor at the RWTH University and DWI-Leibniz Institute for Interactive Materials (Aachen, Germany). In her ERC Starting Grant Anisogel, her team designs low-invasive, polymeric hydrogel therapies that orient after injection to repair anisotropic tissues. In addition, dynamic hydrogels are created to study mechanobiology.
 


University of Washington

Dr. Cole A. DeForest is the Dan Evans Career Development Assistant Professor in the Departments of Chemical Engineering and Bioengineering at the University of Washington, where he began in 2014. His research program focuses on the development and exploitation of user-programmable biomaterials for 4D cell culture and targeted drug delivery. He has authored >50 peer-reviewed articles, including as the corresponding author for those appearing in Nature Materials, Nature Chemistry, Advanced Materials, JACS, Science Advances, and Nature Reviews Materials. His research has been supported through fellowships and grants from the NSF, NIH, HHMI, and the US Department of Education.


Julius Wolff Institut, Charité - Universitätsmedizin Berlin

Vize-Speaker Berlin Institute of Health Center for Regenerative Therapies (BCRT) Spokesperson Einstein Centre Regenerative Therapies (ECRT) & Berlin-Brandenburg School for Regenerative Therapies (BSRT). Immune-therapeutics (including a diagnostic kit identifying healing problems), expertise in mechano-biologically optimized healing, guided tissue regeneration by biomaterial scaffolds and bone formation induced by stress-relaxing scaffolds are our research foci. Findings of principles in bone healing are transferred to muscle and ligament regeneration. Immuno-therapeutic and mechano-therapeutic cues open novel avenues for regenerative therapies to restore tissue homeostasis in medical challenged patient settings.


National University of Ireland Galway

Professor Garry Duffy is Personal Professor in Anatomy & Regenerative Therapies, within the School of Medicine at the National University of Ireland Galway. He leads the Duffy Lab at NUI Galway, which is focused on developing advanced biomaterials and devices to facilitate targeted delivery and future clinical translation of cell and drug based therapeutics to treat chronic diseases.
 

 

 


University Medical Center Hamburg Eppendorf, Institute of Experimental Pharmacology and Toxicology, and German Centre for Cardiovascular Research (DZHK)

Professor Eschenhagen, MD, trained in Cardiology in Hannover and specialized in Experimental Pharmacology and Molecular Biology. He is Director of the Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg Eppendorf, Chairman German Centre for Cardiovascular Research and currently President ISHR-International. He is member of the German Academy of Science Leopoldina. His research is funded through grants from various public bodies, including an ERC AG. He published >320 papers and textbook chapters including leading pharmacology textbooks. His research focusses on molecular cardiology with a focus on heart failure, stem cells and tissue engineering, a technology he pioneered in 1994.


NC State/UNC-CH

Dr. Freytes’ laboratory focuses on the design and testing of bioengineered tissues mainly composed of pluripotent stem cell derived repair cells and tissue specific extracellular matrix scaffolds. The overall goal is to develop new strategies to assemble and test bioengineered constructs capable of restoring tissue function. The major goals of the laboratory are: 1) to harness the power of tissue specific extracellular matrices to guide stem cell differentiation and/or tissue remodeling in vitro and in vivo; and 2) to understand and harness the interaction between inflammatory cells and bioengineered tissue constructs in order to improve incorporation and survival.

 

 


University of Bern

Prof Benjamin Gantenbein is heading the Tissue Engineering for Orthopedics & Mechanobiology (TOM) group at the Medical Faculty at the University of Bern (UBern). Prof Gantenbein acquired experience in modern concepts of tissue engineering and regenerative medicine. He is active in the field of tissue engineering, stem cell research (www.stemcellsbern.ch) using a wider range of bone & joint tissues. He teaches lectures on Tissue Engineering in the Biomedical Masters course at UBern and also teaches regenerative medicine at the University of Fribourg and the University of Basel.


University Medical Center Utrecht

Debby Gawlitta holds a position as Associate Professor heading her lab in the Regenerative Medicine Center Utrecht. She is affiliated with the department of 'Oral and Maxillofacial Surgery' of the University Medical Center Utrecht. Maxillofacial bone and cartilage regeneration are her research foci, with particular expertise in endochondral bone regeneration from a cartilage template and vascularized bone regeneration. Research keywords include clinical translation, biomaterials, stem/progenitor cells, bioreactors, and 3D bioprinting. Her research was supported by a.o. a prestigious Dutch Veni innovation grant and an AO startup grant.


Institute for Transfusion Medicine

Bernd Giebel received his PhD 1996 at the University zu Köln in Developmental Biology. From 1999-2008 he worked at the Heinrich-Heine-University of Düsseldorf on human hematopoietic stem and progenitor cells and set up his own group. Continuing his stem cell research, in 2008 BG moved to the University Hospital Essen and as a 2nd topic started to work with EVs.


Université de Montréal

May Griffith is a professor at the Dept. of Ophthalmology, Université de Montréal, located at the Maisonneuve-Rosemont Hospital Research Centre. MG is mainly recognized for leading a multinational, interdisciplinary team that achieved the world’s first successful regeneration of the human cornea, a tissue that does not regenerate itself. MG and her team used cell-free recombinant human collagen implants that stimulated the patients’ endogenous cells to regenerate a fully functional, innervated neo-cornea as an alternative to corneal transplantation using allografts. For effective clinical translation, MG has teamed-up with world renowned corneal researchers and in efforts to eradicate corneal blindness globally.
 


INSERM U1229-RMeS "Regenerative Medicine and skeleton research centre"

Jérôme Guicheux (50 yo, PhD-DSc 97’) is full professor/senior research director at the French national institute for health and medical research (INSERM). He is director of the research center RMES “regenerative medicine and skeleton” (120 people, INSERM U1229, Nantes, France). He is coordinator of the French INSERM osteoarthritis network. He is a member of the board of directors of OARSI and Regenerate-Biospine. He has authored more than 190 indexed publications (google scholar H-index 60, total citations >9000). His research focuses on the pathophysiology of skeletal tissues and biomaterials/stem cells-based regenerative medicine of cartilage and intervertebral disc. Researcher ID: F-7767-2013


THT Biomaterials GmbH

Dr. Hackethal finished his Master studies in “Tissue Engineering and Regenerative Medicine” at FH Technikum Vienna, Austria and “Medical biology” at Linköping University, Sweden. His doctoral thesis was performed at BOKU Vienna, Austria and the Ludwig-Boltzmann-Institute for Experimental and Clinical Traumatology under supervision of Prof.Dr. Heinz Redl (Hackethal et al., 2017. TEC 23(5); Hackethal et al., 2018. Advances in Experimental Medicine and Biology, DOI 10.1007/97898113094721, PCT/EP2019/058534). After finishing pHD, in June 2020, Dr. Hackethal founded THT Biomaterials GmbH, with the aim, to realize an affordable, sustainable and personalized Medicine by use of non-cellular human proteins from placenta.
 


University of Cambridge

Dr Yan Yan Shery Huang leads the Biointerface group at the Department of Engineering, University of Cambridge. She obtained MEng degree in Materials Science and Engineering from Imperial College London; then completed her PhD thesis in the field of Experimental Soft Matter under theoretical physicist, Prof Eugene Terentjev at the University of Cambridge. After graduating from her PhD in 2011, she was awarded an Oppenheimer Fellowship and a Homerton College Junior Research Fellowship. She is a recipient of an ERC-starting grant award, and is a fellow of the Institute of Materials, Minerals and Mining (FIMMM).
 


The Ohio State University

Amanda Hummon earned her A.B. in chemistry at Cornell University and her Ph.D. in analytical chemistry at the University of Illinois, in the laboratory of Prof. Jonathan V. Sweedler. She completed her postdoctoral work at the National Cancer Institute. She is currently an associate professor in the Department of Chemistry and Biochemistry and the Comprehensive Cancer Center at The Ohio State University. Her laboratory develops mass spectrometric methods to explore cancer tissues, cell cultures, and organoids. She has been recognized with an NSF CAREER award, the Presidential Early Career Award for Scientists and Engineers (PECASE), and a Fulbright Scholar Award.


Tufts University

David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering to understand structure-function relationships and on tissue engineering and regenerative medicine. His lab has published over 900 peer reviewed papers, he is the editor-in-chief of ACS Biomaterials Science and Engineering, and he serves on many editorial boards and programs for journals and universities, and has received a number of awards for teaching and research.
 


Terasaki Research Institute

Ali Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. He is also a researcher at Amazon Web Services Inc. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). Previously, he was a Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology, Brigham and Women’s Hospital and an associate faculty at the Wyss Institute for Biologically Inspired Engineering. He received his Ph.D. in bioengineering from MIT, and MASc and BASc degrees from University of Toronto both in chemical engineering.


Mayo Clinic

James L. Kirkland, M.D., Ph.D., is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland’s research is on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities. He published the first article about agents that clear senescent cells – senolytic drugs. He is a scientific advisory board member for multiple companies, academic organizations, and governments.

 


Eindhoven University of Technology

Dr. Nicholas Kurniawan is an Assistant Professor at the Department of Biomedical Engineering in Eindhoven University of Technology, the Netherlands. His research focuses on understanding how the physical and mechanical interactions between cells and cellular environments shape physiological tissue function and drive pathologies. His interdisciplinary team combines approaches from biophysics, mechanobiology, microfabrication, and cell biology with an outlook of exploiting cell–materials interactions for regenerative medicine applications. His work is supported by grants from the European Research Council, the Dutch Research Council, the Dutch Ministry of Economic Affairs and Climate Policy, and the Dutch Ministry of Education, Culture and Science.


Sheffield Hallam University

Christine is Professor of Cell biology and Tissue Regeneration and leads the Tissue Engineering and Biomechanics Research Group at Sheffield Hallam University, UK. Her research focuses on understanding the pathogenesis of musculoskeletal disorders and utilising this knowledge to develop novel therapeutic approaches. Her research to date has led to >20 million in research funding, 2 patent families, ~80 peer reviewed publications with a current H index of 34 and ~6000 citations on her work to date. She has supervised 14 doctoral students to completion and currently supervises 7 doctoral students.


Peking University People's Hospital

Jianhao Lin is a leader in joint surgery in China, with research interests in the development of cartilage regeneration and joint reconstruction strategies. He is Head of the Arthritis Clinic and Research Center at Peking University, Chair of the Beijing Joint Health Foundation, and Chair of the Asian Alliances Committee of Osteoarthritis Research Society International (OARSI). His basic science research focuses on the physical microenvironment of MSCs and their applications in tissue engineering and regenerative medicine, particularly for musculoskeletal tissues. He serves on many journal editorial boards including HSS and OAC Open.


University of Pennsylvania

Claudia Loebel is currently a postdoctoral fellow in the laboratory of Professor Jason Burdick at the University of Pennsylvania (United States). She obtained her MD (2011) at the Martin-Luther University Halle-Wittenberg (Germany) and completed her PhD (2016) at ETH Zurich and the AO Research Institute (Switzerland). She has been awarded the Silver Medal of ETH and postdoctoral fellowships by the Swiss National Science Foundation and IBSA Foundation. Her research interests are on the development of biomaterial platforms to address specific problems related to tissue repair and therapeutic treatment.


University of Aveiro

João F. Mano is a Full Professor at the Chemistry Department of University of Aveiro, Portugal. He is the director of the COMPASS Research Group, from the research unit CICECO – Aveiro Institute of Materials, focusing on the use of advanced biomaterials and cells towards the progress of transdisciplinary concepts to be employed in regenerative and personalised medicine. He is the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating several national and European research projects, including Advanced and Proof-of-Concept Grants from the European Research Council.


Heart Institute Cedars-Sinai Medical Center

Eduardo Marbán, MD, PhD, is an international leader in cardiology and a pioneering heart researcher. His 30-plus years of experience in patient care and research have led to key discoveries in gene- and cell-based therapies for heart disease. Those discoveries have formed the basis for multiple startup companies. In 2007, Marbán became founding director of the Cedars-Sinai Heart Institute, which was renamed the Smidt Heart Institute in 2018. The Smidt Heart Institute has been ranked by US News and World Report as the top heart program in the western USA since 2013.


TissUse GmbH, Technische Universität Berlin

Since 2010 Uwe Marx is the CEO and founder of TissUse, a “Human-on-a-chip” spin-off company of the Technische Universität Berlin. He pioneered various programs in the “Multi-organ-chip” field. Between 2000 and 2010 Dr. Marx joined German the biotech ProBioGen, whichnhe founded in 1994, as the Chief Scientific Officer. Prior to that, he spent his scientific career at the University of Leipzig (1995-2000) and at the Charité Berlin (before 1995). He received his doctorate degree in immunology from the Humboldt University, Charité in Berlin. Dr. Marx has published more than 60 peer-reviewed papers and is inventor in 26 patent families. https://en.wikipedia.org/wiki/Uwe_Marx.


Utrecht Institute for Pharmaceutical Sciences, div. Pharmacology

Roos Masereeuw (UU) received her PhD from Radboud University in Nijmegen in January 1997 and joined the Dept. of Pharmacology and Toxicology at Radboudumc as assistant professor. In July 2002, she was appointed as associate professor after obtaining an NWO-ASPASIA award. In 2009, she received the Dutch Pharmacological Society (NVF) Schering-Plough Pharmacology Award, in 2010 the Prix Galien Research Award and in 2015 she was elected Fellow of the American Association of Pharmaceutical Scientists. Since July 2015 she is full professor of Experimental Pharmacology and since November 2018 scientific director of Utrecht Institute for Pharmaceutical Sciences in The Netherlands.


University of Nottingham

Alvaro Mata is Professor in Biomedical Engineering and Biomaterials in the School of Pharmacy and the Department of Chemical and Environmental Engineering at the University of Nottingham. He holds a Doctor of Engineering Degree working with Prof. Shuvo Roy at the Cleveland Clinic prior to postdoctoral training working with Prof. Samuel Stupp at Northwestern University. His group aims to harness biomolecules and supramolecular events found in nature to develop innovative materials and biofabrication processes. His work has led to seven patents or patent applications and publications in journals including Nature Materials, Nature Chemistry, Nature Communications, and Advanced Functional Materials.


Aarhus University

Rikke Meyer is PhD in microbiology and Associate professor at the Interdisciplinary Nanoscience Center at Aarhus University, Denmark. She is heading a research group that studies now bacteria form biofilms, and how to prevent or treat biofilms by exploiting recent advancements in nanotechnology. Her research addresses the fundamental questions of how bacteria interact with material surfaces, and she brings this knowledge into application in collaboration with industry partners from the health, food, and water technology sectors.


Harvard University

David Mooney is the Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute. His laboratory designs biomaterials to promote regeneration and immunotherapy. He is a member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. His inventions have been licensed by over 15 companies, leading to commercialized products. He has founded companies, and is active on industrial scientific advisory boards.


Ecole Polytechnique Federale de Lausanne

Christophe Moser is Associate professor of optics and Section Director in the MicroEngineering Institute at EPFL. His current research interests are micro-endoscopic imaging through multimode fibers, retinal imaging and additive manufacturing via volumetric 3D printing with light. His group developed a single photon volumetric 3D bioprinter technology capable of printing high resolution centimeter scale live cell laden complex constructs in matters of seconds by tomographic back-projection. He holds a PhD from Caltech and was the CEO of Ondax for 10 years prior to joining EPFL. He is the author and co-author of 75 peer reviewed publications and over 50 patents.


University of Milano-Bicocca

Francesco Nicotra professor of Organic Chemistry at University of Milano-Bicocca, Past-President of the IUPAC Division of Organic and Biomolecular Chemistry, Italian representative in the International Carbohydrate Organization. Scientific interests in Bio-organic chemistry, with particular attention to glycoscience. Recipient of the Award for innovation in research of the Italian Chemical Society; the Medal Berti for Research in Carbohydrate Chemistry and the Medal Quilico of the Division of Organic Chemistry of the Italian Chemical Society. Plenary and Keynote speaker in > 50 International Conferences. >200 publications, 18 chapters of books, 12 patents, H index 39 (Google Scholar), 34 (Scopus)


Medical University of Vienna, Department of Orthopedics and Trauma-Surgery, Division of Trauma Surgery

Sylvia Nürnberger, PhD is a principle investigator at the Medical University of Vienna, Department of Orthopedics and Trauma-Surgery and the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology. She has studied Biology at the University of Vienna and is since 2014 the scientific head of the “Cartilage Regeneration” group of the “Austrian Cluster of Tissue Regeneration”. A strong focus of her work is the development and characterization of biomaterials (scaffolds and glues) and alternative cell therapies. Together with her group and collaboration partners, she recently developed and patented different strategies for repopulation of decellularized cartilage.


University of Zaragoza

María Angeles Pérez is Full Professor of Structural Mechanics at the University of Zaragoza (Spain). Her research focusses on the multiscale and multi-physics modelling of biological processes (bone remodeling, tissue engineering and cellular mechanobiology). María Angeles is the PI of the research group Multiscale in Mechanical and Biological Engineering (M2BE), where they combine computational models (in silico) with experimental data (in vitro) obtained from their cellular mechanobiology lab. She has been President of the European Society of Biomechanics (2018-2020) and now is Associate Director of the Aragón Institute of Engineering Research (I3A).
 


Department of Materials Science and Engineering, University of Sheffiel

Professor Ipsita Roy is an expert in Microbial Biotechnology, Biomaterials and Tissue Engineering. She is currently a Professor at the Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield. She was awarded the Inlaks Scholarship to study for her Ph.D. at the University of Cambridge. Her postdoctoral work was at the University of Minnesota, USA. She has published over 100 papers in high ‘Impact Factor’ journals such as Biomaterials, Biomacromolecules, Journal of Royal Society Interface. Her group is currently focussed on the production of natural polymers, including Polyhydroxyalkanoates (PHAs), Bacterial cellulose, Alginate, their characterisation and biomedical applications.

 


University of Glasgow

Manuel is Professor of Biomedical Engineering and co-director of the Centre for the Cellular Microenvironment at the University of Glasgow. He did a PhD in Valencia and postdoctoral research in Prague and Leuven. He was Full Professor at Universitat Politecnica de Valencia and Visiting Professor in Georgia Tech. His group has pioneered polymers that trigger the self-assembly of proteins to promote high efficiency presentation of growth factors. His research lies at the cell/material interface, with interests in in vitro models for drug screening and disease modelling, along with materials for cancer research, stem cell engineering and regenerative medicine.


Living Systems Institute, University of Exete

After secretion, developmental signals such as the Wnt morphogens must travel relatively long distances to form a concentration gradient that the responding tissue uses to acquire positional information. The role of Wnt transport and endocytic trafficking in this process is the subject of intense debate. My team has shown that Wnt is transported on long, actin-based filopodia - known as cytonemes to contact responding cells and activate signalling in human gastric tumour tissue and zebrafish embryogenesis. We are in the process of deciphering the molecular mechanism controlling cytoneme formation and the consequences on cell signalling and tissue development and homeostasis.


Queen Mary University of London

Hazel Screen is Professor of Biomedical Engineering at Queen Mary University of London. Her research centres on healthy and pathological tissue structure-function behaviour and its interplay with mechanobiology. She has a particular interest in tendon and ligament, and leads a highly multidisciplinary group which spans human and animal in vivo and in vitro studies of tendon function and injury. She also leads the UK Organ-on-a-Chip Technologies Network and is interested in developing novel in vitro models of musculoskeletal tissues which integrate learning from structure-function studies to recapitulate appropriate physiochemical cues.
 


AO Research Institute Davos

Tiziano Serra is a research scientist at Sound Guided Tissue Regeneration group in AO Research Institute Davos (ARI). He is also CSO and co-founder of mimiX Biotherapeutics (mimixbio.com). Tiziano has been awarded the Young Investigator Award from the International Society of Biofabrication and the Julia Polak European Doctoral Award from the European Society of Biomaterials. His research activities are focused on the development of advanced biofabrication technologies for the generation of complex multicellular systems for drug screening and clinical translation.

 


Nationwide Children's Hospital

1983 M.D. Hiroshima University, School of Medicine 1994-1997 Research fellows in Children's Hospital, Boston, Harvard Medical School 1998- 2001 Assistant Professor, Department of Pediatric Cardiovascular Surgery, Tokyo Women's Medical University 2001-2004 Associate Professor, The institute of Advanced Biomedical Engineering & Science, Tokyo Women’s Medical University 2004-2006 Professor, Division of Cardiovascular Tissue Engineering, Tokyo Women’s Medical University 2007-present Visiting Professor, Department of Cardiovascular Surgery, Tokyo Women’s Medical University 2007-2012 Director of Pediatric Cardiovascular Surgery, Yale New Haven Hospital 2012-present Professor of Surgery, Ohio Stage University Director of Cardiovascular Tissue Engineering Program, Nationwide Children’s Hospital


Eindhoven University of Technology

Anthal Smits is Assistant Professor at the Department of Biomedical Engineering and the Insitute for Complex Molecular Systems at Eindhoven University of Technology. He set up and leads the ImmunoRegeneration Group, which specializes in immunomodulation to induce in situ tissue regeneration. The main research goal is to gain a mechanistic understanding of the interactions between human immune cell behavior, biomaterial design, and biomechanical loads, in conditions of health and disease. Smits’ main clinical target applications are cardiovascular replacements (e.g. heart valves and blood vessels), yet, the research is curiosity-driven, and applicable to a wide variety of clinical applications.

 


AO Research Institute Davos

Prof. Martin Stoddart has a Principal Scientist at the AO Research Institute Davos Since 2009. In 2020 he became head of the Regenerative Orthopaedics Program. He is Professor at Albert-Ludwigs University, Freiburg, Germany and an Honorary Professor at Keele University, UK. In 2016 he became Fellow of the Royal Society of Biology and ICRS Fellow Member. He is Chair of LearnORS and scientific editor for eCM Journal. He is a member of the TERMIS EU Meeting and Sponsorship Committee and the International Consortium for Regenerative Rehabilitation Leadership Council. He is the author of over 120 scientific papers and book chapters.


McGill University

Maryam Tabrizian is Canada Research Chair holder in Regenerative Medicine and Nanomedicine, cross-appointed between Faculty of Medicine-Biomedical Engineering Department and the Faculty of Dentistry at McGill University. She was the founding director of the Centre for Biorecognition and Biosensors and has received many prestigious awards (Career award, Guggenheim foundation, Biomaterials Science & Engineering, RSC-Academy of Science, ADEA Leadership Institute, Canadian Academy of Health Sciences,..). She is expertise in the design of advanced biomaterials and biointerfaces for their applications in nanomedicine, regenerative medicine and Lab-on-a-chip devices. Professor Tabrizian authored over 235 papers (H-index 61) and is the EIC of Materials (MDPI).


The Chinese University of Hong Kong

Prof. Tuan (Ph.D., Rockefeller University) was a professor at the University of Pennsylvania and Thomas Jefferson University, and Chief of the Cartilage Biology and Orthopedics Branch of the NIH, prior to joining the University of Pittsburgh in 2009 as Founding Director, Center for Cellular and Molecular Engineering, and Professor and Executive Vice Chair, Department of Orthopaedic Surgery, and Professor in the Department of Bioengineering. In 2018, Prof. Tuan moved to Hong Kong and became the Eighth Vice-Chancellor and President of The Chinese University of Hong Kong, and also founded the Institute for Tissue Engineering and Regenerative Medicine at CUHK.
 


RWTH Aachen Medical School

Wolfgang Wagner is Professor of Stem Cell Biology and Cellular Engineering at RWTH Aachen University Medical School (Germany) since 10 years. Furthermore, he is cofounder of the company Cygenia (www.cygenia.com) that provides service for epigenetic analysis for other scientists since 2014. Prof. Wagner is Editor of the journals PLoS ONE, Scientific Reports and Clinical Epigenetics. His main research interests are 1) epigenetics in hematopoietic differentiation; 2) standardization and characterization of mesenchymal stem cells; 3) interaction of stem cells with biomaterials; and 4) molecular and epigenetic effects of aging, replicative senescence, and malignant transformation.


Cornell university

Dr. Van de Walle received her DVM degree from the Faculty of Veterinary Medicine, Ghent University, Belgium, followed by a PhD from the same institution. She is currently an Associate Professor at the Baker Institute for Animal Health, Cornell University, where she runs her research lab working in the fields of Virology and Stem Cell Biology. In 2016, she was awarded the Zoetis Animal Health Award for Research Excellence, and was named the Harry M. Zweig Assistant Professor in Equine Health in 2017. She has published over 100 papers in peer-reviewed journals and presented at numerous national and international conferences.
 


Max Planck Institute for Polymer Research

Prof. Dr. Tanja Weil joined the Max Planck Society in 2017 as one of the directors of the Max Planck Institute for Polymer Research, heading the division “Synthesis of Macromolecules”. She studied chemistry (1993–1998) at the TU Braunschweig (Germany) and the University of Bordeaux I (France) and completed her PhD at the MPI for Polymer Research under the supervision of K. Müllen. Her scientific interests focus on innovative synthesis concepts to achieve functional macromolecules and hybrid materials to solve current challenges in biomedicine and material science.
 


University of Leeds

Dr Yang (University of Leeds, UK), the head of tissue engineering research, has over 12 years of expertise in clinical orthopaedics and 20 years in bone and cartilage tissue engineering research using stem cell therapy, biomimetic biomaterials and in vitro, in vivo models. He filed 9 patents and published over 100 book/articles/papers. He has given 40 keynote/invited talks. He developed and provide leadership for six international consortia in regenerative medicine. XY has been the Honorary Treasurer and Trustee of the British Orthopaedic Research Society, a member of the scientific committees for many prestigious conferences, grant review panels and editorial boards.


Wake Forest Institute for Regenerative Medicine

Dr. Yoo is a Professor and Associate Director of the Wake Forest Institute for Regenerative Medicine (WFIRM). Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo has been involved in transferring several cell-based technologies from the bench-top to the bedside. Dr. Yoo has also been a lead scientist in the bioprinting program at WFIRM and has been instrumental in developing skin bioprinting and integrated tissue and organ printing (ITOP) systems for preclinical and clinical applications.


Shenzhen University

Yang Zhang obtained his Ph.D. degree and postdoctoral experience from Radboud University Medical Center, the Netherlands. After that, he joined Shenzhen University as an associate professor. His current research focuses on unraveling roles of the immune microenvironment in tissue regeneration, where he has published more than 20 journal articles. He served as a 29th ESB Academic Committee member and as a peer reviewer for Biomaterials Science, Tissue Engineering, Journal of Biomedical Materials Research, etc. He was also a visiting researcher at Johannes Gutenberg University Mainz (Germany) and Capital Medical University (China).


Harvard Medical School

Dr. Zhang's research interests include 3D bioprinting, organ-on-a-chip, regenerative engineering, and bioanalysis. His scientific contributions have been recognized by >40 awards. He is an author of >190 peer-reviewed publications (H-index: 53) and has delivered >110 invited lectures globally. He is serving as Co-Editor-in-Chief for Microphysiological Systems, and is an Associate Editor for Bio-Design and Manufacturing, Essays in Biochemistry, and Nano Select. He is also on the Editorial Board of Biofabrication, Bioprinting, Advanced Healthcare Materials, BMC Materials, and Chinese Chemical Letters, and Editorial Advisory Board of Heliyon and Biomicrofluidics, and Advisory Panel of Nanotechnology.